A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care

MedGenMed Medscape General Medicine

Volumn 8, Issue 2, 2006, Pages

  Kozal, Michael J ^a   Amico, K Rivet ^b   Chiarella, Jennifer ^c   Cornman, Deborah ^b   Fisher, William ^d   Fisher, Jeffrey ^b   Friedland, Gerald ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG CLASSIFICATION; FEMALE; GENOTYPE; HEALTH SURVEY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; POPULATION RESEARCH; PREVALENCE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; SELF REPORT; SEX RATIO; SEXUAL BEHAVIOR; SEXUALITY; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; CROSS-SECTIONAL STUDY; HIGH RISK BEHAVIOR;

ADULT; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; RISK-TAKING; SEXUAL BEHAVIOR;

EID: 33745223480     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Little SJ, Holte S, Route J, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385-394. Abstract
2. Grant RM, Hecht FM, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002;288:181-188. Abstract
3. Weinstock HS, Zaidi I, Heneine W, et al. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis. 2004;189:2174-2180. Abstract
4. Novak RM, Chen L, MacArthur RD, et al., for the CPCRA 058 Study Team. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment naïve participants in the cpcra first study: implications for routine resistance screening prior to initiating antiretroviral therapy. Clin Infect Dis. 2005;40:468-474. Abstract
5. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature. 2002;420:434-439. Abstract
6. Jost S, Bernard MC, Kaiser L, et al. A patient with HIV-1 superinfection. N Engl J Med. 2002;347:731-736. Abstract
7. Ramos A, Hu DJ, Nguyen L, et al. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol. 2002;76:7444-7452. Abstract
8. Markowitz M, Mohri H, Mehandru S, et al. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet. 2005;365:1031-1038. Abstract
9. Kozal MJ, Amico KR, Chiarella J, et al. Antiretroviral resistance and high-risk transmission behavior among HIV+ patients in clinical care. AIDS. 2004;18:2185-2189. Abstract
10. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403-1409. Abstract
11. Hecht FM, Grant RM, Petropoulos CJ, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse transcriptase and protease inhibitors. N Engl J Med. 1998;339:307-311. Abstract
12. Chin-Hong PV, Deeks S, Liegler T, et al. High risk sexual behavior in HIV-infected adults with genotypically proven antiretroviral resistance. J Acquir Immune Defic Syndr. 2005;40:463-471. Abstract
13. Fisher JD, Fisher WA, Cornman DH, Amico KR, Bryan A, Friedland G. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41:44-52. Abstract
14. Kozal MJ, Amico KR, Chiarella J, et al. HIV drug resistance and HIV transmission risk behaviors in injection drug users. J Acquir Immune Defic Syndr 2005;40:106-109.
15. Johnson VA, Brun-Vezenit B, Clotet B, et al. Drug resistance mutations in HIV-1. Top HIV Med. 2004;12:119-124. Abstract
16. Tabachnick B G, Fidell L S. Using Multivariate Statistics. 2nd ed. New York: Harper Collins Publishers; 1989.
17. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000; 342:921-929. Abstract
18. Sethi AK, Celentano DD, Gange SJ, Gallant JE, Valhov D, Farazdegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr. 2004;35:503-510. Abstract
19. McGowan JP, Shah S, Ganea CE, et al. Risk behavior for transmission of HIV among HIV-seropositive individuals in an urban setting. Clin Infect Dis. 2004;38:122-127. Abstract
20. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. AIDS. 2002;16:135-149. Abstract
21. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review. JAMA. 2004;292:22-36. Abstract
22. Richman DD, Morton S, Wrin T, Hellman N, Berry S, Shapiro MF, et al. The prevalence of antiretroviral drug resistance in the United States. AIDS 2004:18(10):1393-401.
23. Advancing HIV prevention: New strategies for a changing epidemic - United States, 2003. MMWR. 2003;52:329-332.
24. Burman W, Neuhaus J, Rietmeijer C, Douglas J, McCartin C. HIV transmission risk among patients enrolled in a large clinical trial evaluating treatment interruption. Program and abstracts of the XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand. Abstract ThPeD7625.
25. Ciccarone DH, Kanouse DE, Collins RL, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. Am J Public Health. 2003;93:949-954. Abstract
26. WHO. 3 by 5 December 2003 Progress Report Through June 2004. Geneva, Switzerland: WHO; 2004.
27. Schreibman T, Friedland G. Human immunodeficiency virus infection prevention: strategies for clinicians. Clin Infect Dis. 2003;36:1171-1176. Abstract